Wall Street ends slightly lower with Fed in focus

(Reuters) - U.S. stocks ended lower on Friday, with investors cautious going into next week's Federal Reserve meeting, while a warning from Broadcom of a broad weakening in global demand weighed on chipmakers. The Dow Jones Industrial Average fell 17.16 points, or 0.07%, to 26,089.61, the S&P 500 lost 4.65 points, or 0.16%, to 2,886.99 and the Nasdaq Composite dropped 40.47 points, or 0.52%, to 7,796.66

Reuters June 15, 2019 03:06:24 IST
Wall Street ends slightly lower with Fed in focus

Wall Street ends slightly lower with Fed in focus

(Reuters) - U.S. stocks ended lower on Friday, with investors cautious going into next week's Federal Reserve meeting, while a warning from Broadcom of a broad weakening in global demand weighed on chipmakers.

The Dow Jones Industrial Average fell 17.16 points, or 0.07%, to 26,089.61, the S&P 500 lost 4.65 points, or 0.16%, to 2,886.99 and the Nasdaq Composite dropped 40.47 points, or 0.52%, to 7,796.66.

(Reporting by Caroline Valetkevitch, Editing by Rosalba O'Brien)

This story has not been edited by Firstpost staff and is generated by auto-feed.

Updated Date:

TAGS:

Find latest and upcoming tech gadgets online on Tech2 Gadgets. Get technology news, gadgets reviews & ratings. Popular gadgets including laptop, tablet and mobile specifications, features, prices, comparison.

also read

Libya's Haftar committed to ending oil blockade, U.S. says
Business

Libya's Haftar committed to ending oil blockade, U.S. says

CAIRO (Reuters) - Libyan commander Khalifa Haftar has committed to ending a months-long blockade of oil facilities, the U.S.

AstraZeneca resumes UK trials of COVID-19 vaccine halted by patient illness
Business

AstraZeneca resumes UK trials of COVID-19 vaccine halted by patient illness

By Michael Holden LONDON (Reuters) - AstraZeneca has resumed British clinical trials of its COVID-19 vaccine, one of the most advanced in development, after getting the green light from safety watchdogs, the company said on Saturday. The late-stage trials of the experimental vaccine, developed with researchers from the University of Oxford, were suspended this week after an illness in a study subject in Britain, casting doubts on an early rollout

Softbank nears deal to sell Arm Holdings to Nvidia for more than $40 billion - WSJ
Business

Softbank nears deal to sell Arm Holdings to Nvidia for more than $40 billion - WSJ

(Reuters) - SoftBank Group Corp is nearing a deal to sell British chip designer Arm Holdings to Nvidia Corp for more than $40 billion, the Wall Street Journal reported https://on.wsj.com/2Rlv7HC on Saturday, citing sources.